technical analysis

Also watch these areas on KORS and GPRO.
Endo Pharmaceuticals could offer a short-term play.
As long as Pandora closes above $18, it should move higher.
We expect DHR stock to react positively to both moves.
Current pattern should yield higher prices, but resistance awaits.
The bulls will be back in position.
Sagging momentum and breadth indicators are the real issue.
The 50-day moving average is relatively flat.
Cablevision shares may see short-term pressure.
We may be having a turning point here.

Columnist Conversations

Market recovers from yesterday's losses as investors go back into "risk on" mode. Concert Pharmaceuticals (CNC...
We added this name a few weeks back and now it is the talk of the buyout craze. No matter, because like CRM w...
Intel (INTC)'s pattern off the March corrective low (29.31) exhibits bullish form, which "warns us" that INTC ...
Thanks brotha appreciate the love! Keep an eye on $YUM -- funny feeling the Street could get behind the name a...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.